Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bouma

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Orphanet Journal of Rare Diseases|March 2, 2019
Web-based personalised information and support for patients with a neuroendocrine tumour: randomised controlled trialL D de Hosson, G Bouma, J Stelwagen, et al.
Clinical and Experimental Immunology|July 1, 1997
Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD)G Bouma, M Oudkerk Pool, J B Crusius, et al.
Journal of Crohn'S & Colitis|January 16, 2013
The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological studyM L Seinen, D P van Asseldonk, N K H de Boer, et al.
Human Immunology|June 27, 2012
Defective IL-1A expression in patients with Crohn's disease is related to attenuated MAP3K4 signalingC T M van der Pouw Kraan, J M Baggen, A A van Bodegraven, et al.
Scandinavian Journal of Immunology|April 1, 1996
Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel diseaseG Bouma, J B Crusius, M Oudkerk Pool, et al.
BMJ Open Gastroenterology|October 14, 2015
Novel variant of EATL evolving from mucosal γδ-T-cells in a patient with type I RCDR L J van Wanrooij, D de Jong, A W Langerak, et al.
Plos Pathogens|February 9, 2026
Cytotoxic lymphocytes counteract viral type I interferon immune evasionMichael Y Schakelaar, Liling Shan, Shuang Li, et al.
Clinical and Experimental Immunology|February 5, 1999
Genetic markers in clinically well defined patients with ulcerative colitis (UC)G Bouma, J B Crusius, M A García-González, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|December 17, 2003
IL12B and IRF1 gene polymorphisms and susceptibility to celiac diseaseD Seegers, M E A Borm, M J van Belzen, et al.
Oncoimmunology|February 6, 2018
Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastomaJeroen F Vermeulen, Wim Van Hecke, Elisabeth J M Adriaansen, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Orphanet Journal of Rare Diseases|March 2, 2019
Web-based personalised information and support for patients with a neuroendocrine tumour: randomised controlled trialL D de Hosson, G Bouma, J Stelwagen, et al.
Clinical and Experimental Immunology|July 1, 1997
Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD)G Bouma, M Oudkerk Pool, J B Crusius, et al.
Journal of Crohn'S & Colitis|January 16, 2013
The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological studyM L Seinen, D P van Asseldonk, N K H de Boer, et al.
Human Immunology|June 27, 2012
Defective IL-1A expression in patients with Crohn's disease is related to attenuated MAP3K4 signalingC T M van der Pouw Kraan, J M Baggen, A A van Bodegraven, et al.
Scandinavian Journal of Immunology|April 1, 1996
Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel diseaseG Bouma, J B Crusius, M Oudkerk Pool, et al.
BMJ Open Gastroenterology|October 14, 2015
Novel variant of EATL evolving from mucosal γδ-T-cells in a patient with type I RCDR L J van Wanrooij, D de Jong, A W Langerak, et al.
Plos Pathogens|February 9, 2026
Cytotoxic lymphocytes counteract viral type I interferon immune evasionMichael Y Schakelaar, Liling Shan, Shuang Li, et al.
Clinical and Experimental Immunology|February 5, 1999
Genetic markers in clinically well defined patients with ulcerative colitis (UC)G Bouma, J B Crusius, M A García-González, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|December 17, 2003
IL12B and IRF1 gene polymorphisms and susceptibility to celiac diseaseD Seegers, M E A Borm, M J van Belzen, et al.
Oncoimmunology|February 6, 2018
Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastomaJeroen F Vermeulen, Wim Van Hecke, Elisabeth J M Adriaansen, et al.
Pageof 9